Growth • Abbott Laboratories
ABT
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
5,6%
CAGR Revenue 5Y
Revenue Compound Annual Growth Rate in the last 5 years.
8,5%
CAGR Op. Income 5Y
Operating Income Compound Annual Growth Rate in the last 5 years.
29,4%
CAGR Net Income 5Y
Net Income Compound Annual Growth Rate in the last 5 years.
30%
CAGR EPS 5Y
Earnings Per Share Compound Annual Growth Rate in the last 5 years.
29,5%
CAGR Normalized EPS 5Y
Normalized Earnings Per Share Compound Annual Growth Rate in the last 5 years.
6,9%
CAGR OCF 5Y
Cash Flow from Operating activities Compound Annual Growth Rate in the last 5 years.
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!